These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 6269351)
1. In vitro inhibition of cyclic 3' 5',-AMP-phosphodiesterase by a group of structural analogues of glaucine. Petkov V; Stancheva S Acta Physiol Pharmacol Bulg; 1980; 6(3):38-47. PubMed ID: 6269351 [TBL] [Abstract][Full Text] [Related]
2. Effect of papaverine analogues on 3', 5'-adenosine monophosphate phosphodiesterase activity in rat brain. Stancheva S; Uzunov P; Stoytchev T Acta Physiol Pharmacol Bulg; 1980; 6(1):41-7. PubMed ID: 6250318 [TBL] [Abstract][Full Text] [Related]
3. Effects of glaucine and some glaucine derivatives and of their combination with L-DOPA on the brain level of biogenic monoamines. Petkov V; Yanev S; Stancheva S Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):83-92. PubMed ID: 7181577 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological studies of a group of semi-synthetic structural analogues of glaucine. Petkov V; Todorov S; Georgiev V; Petkova B; Donev N Acta Physiol Pharmacol Bulg; 1979; 5(4):3-12. PubMed ID: 543409 [TBL] [Abstract][Full Text] [Related]
5. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents. Marcoz P; Prigent AF; Lagarde M; Nemoz G Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905 [TBL] [Abstract][Full Text] [Related]
6. Effects of inhaled glaucine on pulmonary responses to antigen in sensitized guinea pigs. Pons R; Santamaría P; Suchankova J; Cortijo J; Morcillo EJ Eur J Pharmacol; 2000 May; 397(1):187-95. PubMed ID: 10844113 [TBL] [Abstract][Full Text] [Related]
7. Experimental studies on guanosine 3',5'-cyclic monophosphate levels and airway responsiveness of the novel phosphodiesterase type 5 inhibitor SR 265579 in guinea-pigs. Kapui Z; Schaeffer P; Mikus EG; Boronkay E; Gyürky J; Herbert JM; Pascal M Arzneimittelforschung; 1999 Aug; 49(8):685-93. PubMed ID: 10483515 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro. Shimoyama M; Kawai M; Nasu S; Shioji K; Hoshi Y Physiol Chem Phys; 1975; 7(2):125-32. PubMed ID: 239431 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity. Nagata K; Ogawa T; Omosu M; Fujimoto K; Hayashi S Arzneimittelforschung; 1985; 35(7):1034-6. PubMed ID: 2996562 [TBL] [Abstract][Full Text] [Related]
10. Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries. Birk S; Edvinsson L; Olesen J; Kruuse C Eur J Pharmacol; 2004 Apr; 489(1-2):93-100. PubMed ID: 15063160 [TBL] [Abstract][Full Text] [Related]
11. Studies on the phosphodiesterase in various organs of rats and guinea-pigs of different ages and different sex. Petkov V; Stancheva S Acta Physiol Pharmacol Bulg; 1977; 3(1):38-45. PubMed ID: 197791 [TBL] [Abstract][Full Text] [Related]
12. Antispasmodic action of 1-diethylaminoethyl-3-(p-methoxybenzyl)-2-quinoxalone (P 201-1) and its inhibitory effect on cyclic 3',5'-nucleotide phosphodiesterase (PDE) activity. Hayashi S; Ozawa H Chem Pharm Bull (Tokyo); 1975 Apr; 23(4):810-6. PubMed ID: 171085 [No Abstract] [Full Text] [Related]
13. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships. Ko WC; Shih CM; Lai YH; Chen JH; Huang HL Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679 [TBL] [Abstract][Full Text] [Related]
14. Bronchodilator activity of a nonxanthine phosphodiesterase inhibitor; 2,4-diamino-5-cyano-6-bromopyridine (compound I). Smith PF; Thompson WJ; de Haën C; Halonen M; Palmer JD; Johnson DG J Pharmacol Exp Ther; 1986 Apr; 237(1):114-9. PubMed ID: 2420965 [TBL] [Abstract][Full Text] [Related]
15. Ontogenetic development of 3,5-adenosine monophosphate phosphodiesterase in guinea pig and rat ileum. Stancheva S; Petkov V; Uzunov P Acta Biol Med Ger; 1979; 38(7):959-63. PubMed ID: 232347 [TBL] [Abstract][Full Text] [Related]
16. Effect of some phosphodiesterase inhibitors on two different preparations of adenosine 3',5'-monophosphate phosphodiesterase. Du Moulin A; Schultz J Experientia; 1975 Aug; 31(8):883-4. PubMed ID: 169139 [No Abstract] [Full Text] [Related]
17. [Inhibitory action of newly synthesized 1,3-dimethylxanthine derivatives on the 3',5'-cyclic AMP phosphodiesterase activity of the homogenates of various tissues]. Staneva D; Bogoslovova T; Pankova A Eksp Med Morfol; 1980; 19(3):154-9. PubMed ID: 6252004 [TBL] [Abstract][Full Text] [Related]
18. [Effect of psychotropic preparations on cyclic AMP phosphodiesterase activity in the rat cerebral cortex]. Shchekoldina TG; Vatolkina OE; Libinzon RE Vopr Med Khim; 1978; 24(2):166-9. PubMed ID: 208286 [TBL] [Abstract][Full Text] [Related]
19. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor. Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885 [TBL] [Abstract][Full Text] [Related]
20. Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition. Kaheinen P; Pollesello P; Hertelendi Z; Borbély A; Szilágyi S; Nissinen E; Haikala H; Papp Z Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):74-8. PubMed ID: 16433895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]